CytomX Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 32.71 M | $122.68 M | 2.38% | 14.94% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2026 | 21.70 M | $81.39 M | 44.56% | 9.91% |
| BLACKROCK, INC. | 08/07/2026 | 17.56 M | $65.85 M | 235.86% | 8.02% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 15.08 M | $56.56 M | 47.83% | 6.89% |
| STATE STREET CORP | 09/22/2026 | 11.75 M | $44.05 M | 107.42% | 5.37% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 10.44 M | $39.15 M | 3.37% | 4.77% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 8.53 M | $31.97 M | -2.38% | 3.89% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 7.81 M | $29.29 M | -0.82% | 3.57% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 5.17 M | $19.38 M | 44.26% | 2.36% |
| VR ADVISER, LLC | 08/14/2026 | 4.98 M | $18.68 M | -50.09% | 2.28% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 4.98 M | $18.66 M | 0.00% | 2.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 4.68 M | $17.55 M | 126.40% | 2.14% |
| ELMIND CAPITAL, LP | 08/14/2026 | 4.55 M | $17.06 M | 0.00% | 2.08% |
| NEXTECH INVEST, LTD. | 08/14/2026 | 4.45 M | $16.69 M | 0.00% | 2.03% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 4.13 M | $15.50 M | 52.49% | 1.89% |
| EVERSEPT PARTNERS, LP | 08/14/2026 | 3.56 M | $13.34 M | 11.60% | 1.63% |
| UBS GROUP AG | 08/13/2026 | 3.47 M | $13.01 M | 11.16% | 1.58% |
| SIREN, L.L.C. | 08/13/2026 | 3.46 M | $12.97 M | 0.00% | 1.58% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 3.37 M | $12.62 M | -1.32% | 1.54% |
| CITADEL ADVISORS LLC | 09/02/2026 | 3.11 M | $11.66 M | -42.46% | 1.42% |
| MARSHALL WACE, LLP | 08/13/2026 | 3.02 M | $11.34 M | -26.92% | 1.38% |
| WOODLINE PARTNERS LP | 08/14/2026 | 2.04 M | $7.65 M | 1.97% | 0.93% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 2.00 M | $7.51 M | 37.25% | 0.92% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.86 M | $6.98 M | -3.66% | 0.85% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 1.82 M | $6.84 M | -18.89% | 0.83% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.75 M | $6.57 M | 120.34% | 0.80% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 1.69 M | $6.32 M | -53.94% | 0.77% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.68 M | $6.28 M | 173.66% | 0.77% |
| TUDOR INVESTMENT CORP ET AL | 08/14/2026 | 1.38 M | $5.18 M | 100.00% | 0.63% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.27 M | $4.75 M | 14.92% | 0.58% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 1.09 M | $4.07 M | 192.25% | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 879.00 K | $3.30 M | 299.55% | 0.40% |
| ALLY BRIDGE GROUP (NY) LLC | 08/14/2026 | 775.00 K | $2.91 M | -13.89% | 0.35% |
| DV EQUITIES, LLC | 08/14/2026 | 714.00 K | $2.68 M | 100.00% | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 08/14/2026 | 704.42 K | $2.64 M | -37.12% | 0.32% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 700.00 K | $2.63 M | -22.22% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 684.54 K | $2.57 M | 136.16% | 0.31% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 663.04 K | $2.49 M | 43.07% | 0.30% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 599.70 K | $2.25 M | 5.48% | 0.27% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 549.88 K | $2.06 M | 326.93% | 0.25% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 549.88 K | $2.06 M | 100.00% | 0.25% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 505.06 K | $1.89 M | -14.75% | 0.23% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 484.22 K | $1.82 M | 27.37% | 0.22% |
| SCHULHOFF & CO INC | 08/13/2026 | 477.55 K | $1.79 M | 0.00% | 0.22% |
| EXOME ASSET MANAGEMENT LLC | 08/14/2026 | 460.07 K | $1.73 M | -11.77% | 0.21% |
| NUVEEN, LLC | 08/11/2026 | 448.04 K | $1.68 M | 100.00% | 0.20% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 438.41 K | $1.64 M | 90.61% | 0.20% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 420.00 K | $1.58 M | 0.00% | 0.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 372.00 K | $1.40 M | 22.98% | 0.17% |
| ASSENAGON ASSET MANAGEMENT S.A. | 08/21/2026 | 364.17 K | $1.37 M | 0.00% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CytomX Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 258 institutional investors and hedge funds held shares of CytomX Therapeutics Inc. The most heavily invested institutionals were:
FMR LLC: 32.71 M
Kynam Capital Management, LP: 21.7 M
BlackRock, Inc.: 17.56 M
BANK OF AMERICA CORP /DE/: 15.08 M
STATE STREET CORP: 11.75 M
PERCEPTIVE ADVISORS LLC: 10.44 M
97.56% of CytomX Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 226.41 M shares in the last 24 months. This purchase volume represents approximately $1.14 B in transactions.